Am J Transplant, Volume 16, Suppl 3 Archives - Page 136 of 180 - ATC Abstracts

2016 American Transplant Congress
Deceased Organ Donor Factors Influencing Pancreatic Graft Transplantation and Survival.
M. Sally, M. Ellis, T. Groat, X. Gao, S. De la Cruz, M. Patel, D. Malinoski.
Section of Critical Care, Portland VA Health Care System, Portland, OR.
Criteria for organ acceptance remain inconsistent in pancreatic transplantation. The lack of predictive criteria limits the ability to standardize critical care practices in management of…
2016 American Transplant Congress
A Comprehensive Biomarker Study to Compare Tacrolimus and Mycophenolic Acid versus Half-Dose Tacrolimus and Everolimus in De Novo Kidney Transplant Patients in the Novartis US92 Study.
J. Klepacki,¹ J. Klawitter,¹ J. Klawitter,¹ A. Karimpour-fard,² E. Anderson,¹ G. Ingle,³ D. Patel,³ K. Johnson,⁴ D. Cibrik,⁴ U. Christians.¹
¹University of Colorado Denver, Aurora, CO; ²University of Colorado Denver, Aurora, CO; ³Novartis Pharmaceuticals, East Hannover, NJ; ⁴University of Michigan, Ann Arbor, MI.
In this exploratory biomarker sub-study, a comprehensive combined targeted/ non-targeted metabolomics and targeted proteomics approach was used to assess potential differences between the everolimus+ low-dose…
2016 American Transplant Congress
Pediatric Patients Benifit from Steroids Free Regimen After Kidney Transplantation: A Meta-Analysis.
R. Deng, H. Zhang, Y. Zheng, L. Liu, C. Wang.
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Objective: To evaluate the effect of steroids avoidance or withdrawal (SAW) protocol on pediatric recipients by performing a meta-analysis of randomized controlled trials (RCTs).Method: A…
2016 American Transplant Congress
Outcome of the Various Pathology Grades of Antibody-Mediated Rejection After Heart Transplantation.
J. Patel, M. Kittleson, D. Chang, T. Aintablian, L. Czer, A. Trento, J. Kobashigawa.
Cedars-Sinai Heart Institute, Los Angeles, CA.
Background: The pathology scale for antibody-mediated rejection (AMR) was approved by the board of directors in 2013. The ISHLT AMR grading scale consists of pAMR…
2016 American Transplant Congress
Relationship Between Changes in Brain Natriuretic Peptide Levels and Cardiac Allograft Rejection Early After Heart Transplantation.
J. Dann,¹ K. Deininger,¹ D. Reinhold,¹ R. Page II,¹ A. Ambardekar,¹ J. Lindenfeld,² C. Aquilante.¹
¹University of Colorado, Aurora, CO; ²Vanderbilt University, Nashville, TN.
Endomyocardial biopsies (EMBs) are routinely used to detect cardiac allograft rejection after heart transplantation (HTx), but they are invasive and costly. Serial changes in brain…
2016 American Transplant Congress
Frequency and Utility of Donor-Specific Antibody Testing in Simultaneous Liver Kidney Transplant.
A. Morrison,¹ D. Sawinski,² M. Kamoun,³ P. Porrett.¹
¹Surgery, University of Pennsylvania, Philadelphia, PA; ²Medicine, University of Pennsylvania, Philadelphia, PA; ³Pathology, University of Pennsylvania, Philadelphia, PA.
Introduction: The risk of antibody mediated rejection (AMR) in simultaneous liver kidney (SLK) recipients is thought to be lower than in kidney alone patients due…
2016 American Transplant Congress
Kidney Donor Profile Index and Recipient BMI Are Potent Predictors of Six Month Deceased Donor eGFR as Opposed to EPTS.
A. Agarwal, W. Ally, D. Maluf, S. Pelletier, K. Brayman.
University of Virginia Health System, Charlottesville, VA.
Background: Kidney Donor Profile Index (KDPI) has been shown to be predictive of both short and long term graft survival and is used by transplant…
2016 American Transplant Congress
Outcomes of Deceased Donor Kidney Transplantation from Diabetic Donors: Does Presence of Recipient Diabetes Matter?
J. Rogers,¹ A. Farney,¹ G. Orlando,¹ A. Reeves-Daniel,² A. Palanisamy,² H. El-Hennawy,¹ M. Khan,¹ M. Gautreaux,¹ S. Iskandar,³ W. Doares,⁴ S. Kaczmorski,⁴ R. Stratta.¹
¹Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC; ²Internal Medicine, WFBMC, Winston-Salem, NC; ³Pathology, WFBMC, Winston-Salem, NC; ⁴Pharmacy, WFBMC, Winston-Salem, NC.
Donor history of diabetes mellitus (DM) is a known risk factor for inferior graft survival after deceased donor kidney transplantation (DDKT) and is heavily weighted…
2016 American Transplant Congress
Hospitalizations for Cardiovascular Disease After Kidney Transplantation: The Role of Facility Characteristics on Outcomes and Costs.
A. Mathur, Y.-H. Chang, D. Steidley, N. Katariya, A. Singer, W. Hewitt, K. Reddy, N. Wasif, D. Etzioni, A. Moss.
Mayo Clinic, Phoenix, AZ.
Background: Long term outcomes are in jeopardy when kidney transplant recipients are hospitalized with cardiovascular disease (CVD). We sought to understand hospital predictors of inpatient…
2016 American Transplant Congress
Underweight BMI Is Associated with Graft Failure and Increased Mortality in Liver Transplant Recipients.
T. Alhamad,¹ N. Carlsson,² X. Liu,³ J. Wellen,⁴ J. Garonzik-Wang,⁴ S.-H. Chang.²
¹Renal Division, Department of Internal Medicine, Washington University in St. Louis, St. Louis; ² Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis, St. Louis; ³Division of Biostatistics, Washington University in St. Louis, St. Louis; ⁴Department of Surgery, Washington University in St. Louis, St. Louis.
Background:Malnutrition and sarcopenia have been associated with inferior outcomes after liver transplantation. However, little is known about the differential impact of underweight on outcomes based…